Microsoft Stock Is Now Becoming Dead Money (Rating Downgrade)
Microsoft's stock has surged over 25% since mid-last year. Read more to see why I downgrade MSFT from buy to sell.
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...
casavogue1d
Azul royal: 15 ideias para incluir a cor elegante na sua decoração
Sofisticado e versátil, o azul royal inspira produtividade em espaços de trabalho e acolhe em ambientes de convívio e ...
The FDA Is Finally Pulling a Useless Cold Medicine From the Market
Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA ...
FDA proposes removing ineffective decongestant found in most cold medicine
FDA said its proposal was not based on safety concerns, so companies can still market oral drugs containing ... met last year ...